TABLE 2.
Prevalence of metabolic syndrome and individual components in the study (n = 232) and control group (n = 232).
| Variable | Study group |
Control group |
||
|---|---|---|---|---|
| Men (n = 155) | Women (n = 77) | Men (n = 156) | Women (n = 76) | |
| Metabolic syndrome | 16 (10.3) | 29 (37.7)*** | 15 (9.6) | 26 (34.2)*** |
| Elevated waist circumference (cm) | 59 (38.1)† | 64 (83.1)*** | 27 (17.3) | 62 (81.6)*** |
| Elevated blood pressure (mmHg) | ||||
| Systolic | 23 (14.8) | 16 (20.8) | 29 (18.6) | 23 (30.3)* |
| Diastolic | 25 (16.1) | 24 (31.2)** | 31 (19.9) | 24 (31.6)* |
| Elevated fasting plasma glucose (mmol/L) | 16 (10.3) | 16 (20.8)* | 15 (9.6) | 14 (18.4) |
| Elevated serum triglycerides (mmol/L) | 14 (9.0) | 9 (11.7) | 19 (12.2) | 4 (5.3) |
| Low HDL cholesterol (mmol/L) | 65 (41.9)‡ | 56(72.7)*** | 39 (25) | 52 (68.4)*** |
| Number of MetS criteria met | ||||
| 0 | 46 (29.7) | 4 (5.2) | 72 (46.2) | 4 (5.3) |
| 1 | 2 (1.3) | 14 (18.2) | 49 (31.4) | 16 (21.1) |
| 2 | 38 (24.5) | 30 (39) | 20 (12.8) | 30 (39.5) |
| 3 | 12 (7.7) | 20 (26) | 12 (7.7) | 20 (26.3) |
| 4 | 2 (1.3) | 6 (7.8) | 1 (0.6) | 3 (4) |
| 5 | 2 (1.3) | 3 (3.9) | 2 (1.3) | 3 (4) |
HDL, high-density lipoprotein.
Men versus women*p < 0.05; **p < 0.01; ***p < 0.001
†
Elevated waist circumference (cm) in men in study group versus men in control group, p < 0.001; ‡, low HDL cholesterol (mmol/L) in men in study group versus men in control group, p < 0.01.